Regen Biopharma, Inc. Stock Price - RGBP

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Regen Biopharma, Inc. RGBP OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0001 11.11% 0.001 0.001 0.0009 0.001 0.0009 16:59:59
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
17 2,429,723 $ 0.000931 $ 2,263 13,470,502 0.0008 - 0.028
Last Trade Time Type Quantity Stock Price Currency
15:59:35 9,723 $ 0.001 USD

Regen Biopharma, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 449.38k 449.38M $ -7.75M - -0.06 213.9M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Regen Biopharma, Inc. News

Real-Time news about Regen Biopharma, Inc. (QB) (OTCBB): 0 recent articles

Latest RGBP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGBP Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.0010.00110.00080.0009675k30M13M0-
1 Month0.00140.0020.00080.0013675k135M25M-0.0004-28.57%
3 Months0.00250.00320.00080.0015444k135M14M-0.0015-60.00%
6 Months0.00460.00950.00080.0020157k135M10M-0.0036-78.26%
1 Year0.02210.0280.00080.0028202135M5M-0.0211-95.48%
3 Years0.080.170.00080.0066202135M2M-0.079-98.75%
5 Years0.0110.00010.0125202135M1M-0.009-90.00%

Regen Biopharma, Inc. Description

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at
Your Recent History
Regen Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190521 06:28:44